Center for Aortic Surgery and Marfan and Connective Tissue Disorder Clinic, the Department of Thoracic and Cardiovascular Surgery, Heart and Vascular Institute, 9500 Euclid Ave/Mail Stop J4-1, Cleveland, OH 44195, USA.
J Thorac Cardiovasc Surg. 2010 Apr;139(4):926-32.e1-2. doi: 10.1016/j.jtcvs.2009.09.038. Epub 2009 Nov 27.
Less invasive approaches to mitral valve surgery are increasingly used for improved cosmesis; however, few studies have investigated their effect on outcome. We sought to compare these minimally invasive approaches fairly with conventional full sternotomy by using propensity-matching methods.
From January 1995 to January 2004, 2124 patients underwent isolated mitral valve surgery through a minimally invasive approach, and 1047 underwent isolated mitral valve surgery through a conventional sternotomy. Because there were important differences in patient characteristics, a propensity score based on 42 factors was used to obtain 590 well-matched patient pairs (56% of cases).
In-hospital mortality was similar for propensity-matched patients: 0.17% (1/590) for those undergoing minimally invasive surgery and 0.85% (5/590) for those undergoing conventional surgery (P = .2). Occurrences of stroke (P = .8), renal failure (P > .9), myocardial infarction (P = .7), and infection (P = .8) were also similar. However, 24-hour mediastinal drainage was less after minimally invasive surgery (median, 250 vs 350 mL; P < .0001), and fewer patients received transfusions (30% vs 37%, P = .01). More patients undergoing minimally invasive surgery were extubated in the operating room (18% vs 5.7%, P < .0001), and postoperative forced expiratory volume in 1 second was higher. Early after operation, pain scores were lower (P < .0001) after minimally invasive surgery.
Within that portion of the spectrum of mitral valve surgery in which propensity matching was possible, minimally invasive mitral valve surgery had cosmetic, blood product use, respiratory, and pain advantages over conventional surgery, and no apparent detriments. Mortality and morbidity for robotic and percutaneous procedures should be compared with these minimally invasive outcomes.
为了改善美容效果,越来越多的二尖瓣手术采用微创方法;然而,很少有研究调查这些微创方法对结果的影响。我们试图通过倾向评分匹配方法公平地比较这些微创方法与传统的胸骨正中切开术。
1995 年 1 月至 2004 年 1 月,2124 例患者通过微创途径接受了单纯二尖瓣手术,1047 例患者通过传统胸骨正中切开术接受了单纯二尖瓣手术。由于患者特征存在重要差异,因此使用基于 42 个因素的倾向评分获得了 590 对匹配良好的患者(占病例的 56%)。
在倾向评分匹配的患者中,院内死亡率相似:微创组为 0.17%(1/590),传统组为 0.85%(5/590)(P=0.2)。发生中风(P=0.8)、肾衰竭(P>0.9)、心肌梗死(P=0.7)和感染(P=0.8)的情况也相似。然而,微创手术后 24 小时纵隔引流更少(中位数 250 与 350 mL;P<0.0001),接受输血的患者更少(30%与 37%,P=0.01)。微创组更多的患者在手术室拔管(18%与 5.7%,P<0.0001),术后 1 秒用力呼气量更高。术后早期,微创组疼痛评分较低(P<0.0001)。
在二尖瓣手术范围内,当倾向评分匹配成为可能时,微创二尖瓣手术在美容、输血、呼吸和疼痛方面优于传统手术,而没有明显的不利影响。机器人和经皮手术的死亡率和发病率应与这些微创结果进行比较。